OptiNose Statistics
Total Valuation
OptiNose has a market cap or net worth of $95.40 million. The enterprise value is $139.88 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiNose has 10.13 million shares outstanding. The number of shares has increased by 35.93% in one year.
| Current Share Class | 10.13M |
| Shares Outstanding | 10.13M |
| Shares Change (YoY) | +35.93% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 5.36% |
| Owned by Institutions (%) | 44.44% |
| Float | 6.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| Forward PS | 0.92 |
| PB Ratio | -2.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.77
| Current Ratio | 0.77 |
| Quick Ratio | 0.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.81 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.62% |
| Return on Invested Capital (ROIC) | -15.25% |
| Return on Capital Employed (ROCE) | 47.96% |
| Revenue Per Employee | $611,141 |
| Profits Per Employee | -$168,289 |
| Employee Count | 128 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 0.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.52% in the last 52 weeks. The beta is -0.89, so OptiNose's price volatility has been lower than the market average.
| Beta (5Y) | -0.89 |
| 52-Week Price Change | -48.52% |
| 50-Day Moving Average | 8.25 |
| 200-Day Moving Average | 9.31 |
| Relative Strength Index (RSI) | 77.23 |
| Average Volume (20 Days) | 30,085 |
Short Selling Information
The latest short interest is 132,651, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 132,651 |
| Short Previous Month | 142,207 |
| Short % of Shares Out | 1.31% |
| Short % of Float | 2.04% |
| Short Ratio (days to cover) | 1.38 |
Income Statement
In the last 12 months, OptiNose had revenue of $78.23 million and -$21.54 million in losses. Loss per share was -$2.12.
| Revenue | 78.23M |
| Gross Profit | 71.00M |
| Operating Income | -16.32M |
| Pretax Income | -40.91M |
| Net Income | -21.54M |
| EBITDA | -16.04M |
| EBIT | -16.32M |
| Loss Per Share | -$2.12 |
Full Income StatementBalance Sheet
The company has $84.49 million in cash and $128.96 million in debt, giving a net cash position of -$44.48 million or -$4.39 per share.
| Cash & Cash Equivalents | 84.49M |
| Total Debt | 128.96M |
| Net Cash | -44.48M |
| Net Cash Per Share | -$4.39 |
| Equity (Book Value) | -40.36M |
| Book Value Per Share | -4.01 |
| Working Capital | -36.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$44.68 million and capital expenditures -$72,000, giving a free cash flow of -$44.75 million.
| Operating Cash Flow | -44.68M |
| Capital Expenditures | -72,000 |
| Free Cash Flow | -44.75M |
| FCF Per Share | -$4.42 |
Full Cash Flow StatementMargins
Gross margin is 90.76%, with operating and profit margins of -20.86% and -27.54%.
| Gross Margin | 90.76% |
| Operating Margin | -20.86% |
| Pretax Margin | -27.54% |
| Profit Margin | -27.54% |
| EBITDA Margin | -20.50% |
| EBIT Margin | -20.86% |
| FCF Margin | n/a |
Dividends & Yields
OptiNose does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.93% |
| Shareholder Yield | -35.93% |
| Earnings Yield | -22.58% |
| FCF Yield | -46.91% |
Analyst Forecast
The average price target for OptiNose is $9.00, which is -4.46% lower than the current price. The consensus rating is "Hold".
| Price Target | $9.00 |
| Price Target Difference | -4.46% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 23.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 31, 2024. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Dec 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
OptiNose has an Altman Z-Score of -7.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.74 |
| Piotroski F-Score | 3 |